As tech giants pour trillions into AI infrastructure, the insatiable demand for electricity is creating a new class of winners. NextEra Energy, America's largest utility, is emerging as a critical, if unexpected, backbone of the artificial intelligence boom through strategic partnerships with Alphabet and Meta.
AXIS Capital's latest earnings report showcases record underwriting profitability and a significant share repurchase, prompting investors to reassess whether the specialty insurer's disciplined strategy is creating sustainable value or masking underlying risks in a competitive market.
Following a recent pullback in its share price, AutoNation (AN) is back under the microscope. While short-term trading shows weakness, the company's robust multi-year returns present a compelling valuation puzzle for market watchers.
Takeda Pharmaceutical raises its FY2025 revenue and profit guidance following resilient nine-month results and announces U.S. availability of a new ready-to-use immunoglobulin therapy for primary immunodeficiency, fueling discussions on its growth strategy amid high debt and margin pressures.
Recent share price weakness at French construction giant Compagnie de Saint-Gobain has investors questioning its valuation. While a key model suggests the stock is fairly priced, its low P/E ratio compared to peers hints at potential undervaluation, setting the stage for a nuanced debate on the stock's true worth.
Despite a strong 33% gain over the past year, Lear Corporation's recent stock performance shows signs of cooling. A deep dive into its discounted cash flow and earnings multiples suggests the market may still be undervaluing this automotive seating and electronics supplier.
Harmony Biosciences CFO Sandip Kapadia has liquidated his entire direct stake in the company, a move that contrasts sharply with the firm's robust financial performance and bullish $1 billion revenue target for its flagship drug WAKIX by 2026. While the sales were pre-planned, the timing fuels debate on insider confidence versus corporate optimism.
With Bob Iger's anticipated departure, Disney's board prepares to select a new CEO amid investor scrutiny over the company's strategic direction and recent stock performance. The decision is poised to shape priorities for its streaming services, theme parks, and content slate.
Amid a volatile market, EFG International's consistent profit growth and significant insider holdings present a compelling case for stability-focused investors, setting it apart from riskier, loss-making ventures.
The Kospi index plunged over 5% in its sharpest drop since April, halting program trading and dragging down chip giants Samsung and SK Hynix. The selloff, fueled by global risk-off sentiment and doubts over AI spending, tests the resilience of one of the world's hottest equity markets.
At a Singapore aviation conference, FAA Administrator Bryan Bedford publicly accepted the NTSB's findings that agency failures contributed to a mid-air collision that claimed 67 lives, vowing to implement safety reforms.
The UK's economic recovery faces a significant drag from recently implemented fiscal tightening, with growth forecasts remaining subdued for the coming year, according to a leading economic forecaster.
Oracle Corporation announced a massive $45-50 billion fundraising plan for 2026, aiming to aggressively expand its cloud infrastructure to meet surging demand from leading AI and tech giants.
As the EU's landmark 'Next Generation' fund nears its final payout deadlines, its ambitious goal of modernizing the bloc's economy is being hampered by bureaucracy, skills gaps, and questions over long-term sustainability, despite pockets of innovation.
TransDigm Group's recent acquisitions of Stellant Systems and Jet Parts Engineering, totaling over $3 billion, have analysts debating whether the moves solidify its lucrative aftermarket strategy or stretch its leveraged balance sheet too thin ahead of a critical earnings season.
Boston Scientific's latest earnings beat and raised guidance, fueled by strong demand for its electrophysiology devices, signal a strategic shift. The company is navigating tariff pressures while expanding margins, with major acquisitions poised to reshape its long-term profile.
Maplebear's stock has tumbled over 22% in the past year, sparking a fierce debate among investors. While a discounted cash flow model suggests a deep undervaluation, its P/E ratio tells a more cautious story. We break down the conflicting signals and what they mean for the grocery delivery giant's future.
Following a staggering 92.9% one-year surge, Commerzbank shares have cooled slightly. With the stock now trading around €34.69, analysts are divided: deep-value models signal significant upside, while traditional metrics suggest a fair price. We examine the data and the debate shaping one of Germany's banking turnaround stories.
Exelixis shares have delivered impressive multi-year returns, but recent price weakness has investors questioning if the rally has run its course. A deep dive into valuation models suggests the stock may still be significantly undervalued, presenting a potential opportunity amidst market uncertainty.
A fresh price target for Euronext Brussels-listed IT services firm Econocom Group has analysts and investors reassessing the company's trajectory. The update reflects evolving views on the company's strategic positioning and market conditions.
